8-amino-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
AlkaPlorer ID: AK027415
Synonym: None
IUPAC Name: (19S)-8-amino-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
Structure
SMILES: CC[C@@]1(O)C(=O)OCC2=C1C=C1C3=NC4=CC=CC(N)=C4C=C3CN1C2=O
InChI: InChI=1S/C20H17N3O4/c1-2-20(26)13-7-16-17-10(6-11-14(21)4-3-5-15(11)22-17)8-23(16)18(24)12(13)9-27-19(20)25/h3-7,26H,2,8-9,21H2,1H3/t20-/m0/s1
InChIKey: FUXVKZWTXQUGMW-FQEVSTJZSA-N
Source
| Species | Genus | Family | Order | Class | Phylum | Kingdom | Domain |
|---|
Properties Information
Molecule Weight: 363.37300000000016
TPSA?: 107.44
MolLogP?: 1.6618
Number of H-Donors: 2
Number of H-Acceptors: 7
RingCount: 5
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Acinetobacter baumannii | Acinetobacter baumannii | Inhibition | -5.64 | % | 10.6019/CHEMBL4296182 |
| Candida albicans | Candida albicans | Inhibition | 4.9 | % | 10.6019/CHEMBL4296182 |
| Cryptococcus neoformans | Cryptococcus neoformans | Inhibition | -6.8 | % | 10.6019/CHEMBL4296182 |
| Escherichia coli | Escherichia coli | Inhibition | 12.69 | % | 10.6019/CHEMBL4296182 |
| Giardia intestinalis | Putative fructose-1,6-bisphosphate aldolase | Potency | 1409.2 | nM | None |
| Herpes simplex virus (type 1 / strain 17) | Alpha trans-inducing protein (VP16) | IC50 | 1991.0 | nM | None |
| Homo sapiens | 786-0 | GI50 | 10.0 | nM | None |
| Homo sapiens | A498 | GI50 | 79.43 | nM | None |
| Homo sapiens | A498 | ID50 | 10.0 | ng ml-1 | 10.1016/s0960-894x(02)00388-8 |
| Homo sapiens | A549 | GI50 | 18.79 | nM | None |
| Homo sapiens | ACHN | GI50 | 10.0 | nM | None |
| Homo sapiens | Ataxin-2 | Potency | 5011.9 | nM | None |
| Homo sapiens | ATPase family AAA domain-containing protein 5 | Potency | 58.0 | nM | None |
| Homo sapiens | ATP-binding cassette sub-family G member 2 | Activity | nan | None | None |
| Homo sapiens | ATP-dependent DNA helicase Q1 | Potency | 39810.7 | nM | None |
| Homo sapiens | BJ | EC50 | 7.18 | nM | None |
| Homo sapiens | Bloom syndrome protein | Potency | 28183.8 | nM | None |
| Homo sapiens | BT-549 | GI50 | 68.39 | nM | None |
| Homo sapiens | CAKI-1 | GI50 | 10.0 | nM | None |
| Homo sapiens | CCRF-CEM | GI50 | 36.9 | nM | None |
| Homo sapiens | COLO 205 | GI50 | 156.68 | nM | None |
| Homo sapiens | COLO 205 | IC50 | 6.6 | nM | 10.1021/jm990124q |
| Homo sapiens | DLD-1 | GI50 | 566.24 | nM | None |
| Homo sapiens | DMS-114 | GI50 | 10.0 | nM | None |
| Homo sapiens | DMS-273 | GI50 | 10.0 | nM | None |
| Homo sapiens | DNA-(apurinic or apyrimidinic site) lyase | Potency | 35481.3 | nM | None |
| Homo sapiens | DNA polymerase beta | Potency | 50118.7 | nM | None |
| Homo sapiens | DNA polymerase eta | Potency | 22387.2 | nM | None |
| Homo sapiens | DNA polymerase iota | Potency | 79432.8 | nM | None |
| Homo sapiens | DNA polymerase kappa | Potency | 79432.8 | nM | None |
| Homo sapiens | DNA topoisomerase I | Activity | 87.0 | % | 10.1021/np034084b |
| Homo sapiens | DNA topoisomerase I | CC50 | 900.0 | nM | 10.1021/jm00105a017 |
| Homo sapiens | DNA topoisomerase I | IC50 | 110.0 | nM | 10.1021/jm00070a013 |
| Homo sapiens | DNA topoisomerase I | IC50 | 1800.0 | nM | 10.1016/S0960-894X(97)00105-4 |
| Homo sapiens | DNA topoisomerase I | IC50 | 4200.0 | nM | 10.1016/0960-894X(96)00083-2 |
| Homo sapiens | DU-145 | GI50 | 10.0 | nM | None |
| Homo sapiens | EKVX | GI50 | 340.41 | nM | None |
| Homo sapiens | EVSA-T | ID50 | 3.2 | ng ml-1 | 10.1016/s0960-894x(02)00388-8 |
| Homo sapiens | Flap endonuclease 1 | Potency | 17782.8 | nM | None |
| Homo sapiens | Geminin | Potency | 2059.6 | nM | None |
| Homo sapiens | Guanine nucleotide-binding protein G(s), subunit alpha | Potency | 15848.9 | nM | None |
| Homo sapiens | HCC 2998 | GI50 | 110.66 | nM | None |
| Homo sapiens | HCT-116 | GI50 | 27.23 | nM | None |
| Homo sapiens | HCT-15 | GI50 | 196.79 | nM | None |
| Homo sapiens | HepG2 | IC50 | 3.5 | nM | 10.1021/jm990124q |
| Homo sapiens | HepG2 | Potency | 112.2 | nM | None |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -20.21 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -1.39 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | HL-60 | GI50 | 10.0 | nM | None |
| Homo sapiens | HOP-18 | GI50 | 27.73 | nM | None |
| Homo sapiens | HOP-62 | GI50 | 10.0 | nM | None |
| Homo sapiens | HOP-92 | GI50 | 35.65 | nM | None |
| Homo sapiens | Hs-578T | GI50 | 4216.97 | nM | None |
| Homo sapiens | HT-29 | Control | 25.0 | % | 10.1021/jm00070a013 |
| Homo sapiens | HT-29 | GI50 | 63.24 | nM | None |
| Homo sapiens | HT-29 | IC50 | 7.4 | nM | 10.1021/jm990124q |
| Homo sapiens | IGROV-1 | GI50 | 246.04 | nM | None |
| Homo sapiens | IGROV-1 | ID50 | 3.2 | ng ml-1 | 10.1016/s0960-894x(02)00388-8 |
| Homo sapiens | Isocitrate dehydrogenase [NADP] cytoplasmic | Potency | 2059.6 | nM | None |
| Homo sapiens | K562 | GI50 | 112.2 | nM | None |
| Homo sapiens | KM12 | GI50 | 230.14 | nM | None |
| Homo sapiens | KM-20L2 | GI50 | 64.27 | nM | None |
| Homo sapiens | LOX IMVI | GI50 | 10.0 | nM | None |
| Homo sapiens | LXFL 529 | GI50 | 243.78 | nM | None |
| Homo sapiens | Lysine-specific demethylase 4D-like | Potency | 25118.9 | nM | None |
| Homo sapiens | M14 | GI50 | 11.32 | nM | None |
| Homo sapiens | M19-MEL | GI50 | 19.82 | nM | None |
| Homo sapiens | M19-MEL | ID50 | 24.0 | ng ml-1 | 10.1016/s0960-894x(02)00388-8 |
| Homo sapiens | Malme-3M | GI50 | 78.52 | nM | None |
| Homo sapiens | MCF7 | GI50 | 10.0 | nM | None |
| Homo sapiens | MCF7 | ID50 | 3.2 | ng ml-1 | 10.1016/s0960-894x(02)00388-8 |
| Homo sapiens | MDA-MB-231 | GI50 | 272.27 | nM | None |
| Homo sapiens | MDA-MB-435 | GI50 | 118.03 | nM | None |
| Homo sapiens | MDA-N | GI50 | 228.56 | nM | None |
| Homo sapiens | microRNA 21 | Potency | 1309.2 | nM | None |
| Homo sapiens | Microtubule-associated protein tau | Potency | 17782.8 | nM | None |
| Homo sapiens | MOLT-4 | GI50 | 10.0 | nM | None |
| Homo sapiens | Mothers against decapentaplegic homolog 3 | Potency | 461.1 | nM | None |
| Homo sapiens | Mothers against decapentaplegic homolog 3 | Potency | 562.3 | nM | None |
| Homo sapiens | Mothers against decapentaplegic homolog 3 | Potency | 1158.2 | nM | None |
| Homo sapiens | Muscleblind-like protein 1 | Potency | 8912.5 | nM | None |
| Homo sapiens | NCI/ADR-RES | GI50 | 12.79 | nM | None |
| Homo sapiens | NCI-H226 | GI50 | 10.21 | nM | None |
| Homo sapiens | NCI-H226 | ID50 | 7.0 | ng ml-1 | 10.1016/s0960-894x(02)00388-8 |
| Homo sapiens | NCI-H23 | GI50 | 10.0 | nM | None |
| Homo sapiens | NCI-H322M | GI50 | 103.51 | nM | None |
| Homo sapiens | NCI-H460 | GI50 | 10.0 | nM | None |
| Homo sapiens | NCI-H522 | GI50 | 18.11 | nM | None |
| Homo sapiens | Nuclear factor erythroid 2-related factor 2 | Potency | 259.3 | nM | None |
| Homo sapiens | Nuclear factor erythroid 2-related factor 2 | Potency | 651.3 | nM | None |
| Homo sapiens | OVCAR-3 | GI50 | 207.01 | nM | None |
| Homo sapiens | OVCAR-4 | GI50 | 237.68 | nM | None |
| Homo sapiens | OVCAR-5 | GI50 | 127.94 | nM | None |
| Homo sapiens | OVCAR-8 | GI50 | 14.83 | nM | None |
| Homo sapiens | Paired box protein Pax-8 | AC50 | 260.0 | nM | None |
| Homo sapiens | Parathyroid hormone receptor | Potency | 44668.4 | nM | None |
| Homo sapiens | PC-3 | GI50 | 72.78 | nM | None |
| Homo sapiens | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Potency | 31622.8 | nM | None |
| Homo sapiens | Photoreceptor-specific nuclear receptor | IC50 | 895.89 | nM | None |
| Homo sapiens | Ras-related protein Rab-9A | Potency | 2238.7 | nM | None |
| Homo sapiens | RPMI-8226 | GI50 | 76.38 | nM | None |
| Homo sapiens | RXF 393 | GI50 | 40.83 | nM | None |
| Homo sapiens | RXF 631 | GI50 | 37.5 | nM | None |
| Homo sapiens | SF-268 | GI50 | 10.0 | nM | None |
| Homo sapiens | SF-295 | GI50 | 10.0 | nM | None |
| Homo sapiens | SF-539 | GI50 | 10.0 | nM | None |
| Homo sapiens | SK-MEL-2 | GI50 | 232.81 | nM | None |
| Homo sapiens | SK-MEL-28 | GI50 | 177.01 | nM | None |
| Homo sapiens | SK-MEL-5 | GI50 | 11.78 | nM | None |
| Homo sapiens | SK-OV-3 | GI50 | 15.7 | nM | None |
| Homo sapiens | SN12C | GI50 | 10.0 | nM | None |
| Homo sapiens | SN12K1 | GI50 | 22.7 | nM | None |
| Homo sapiens | SNB-19 | GI50 | 10.0 | nM | None |
| Homo sapiens | SNB-75 | GI50 | 11.48 | nM | None |
| Homo sapiens | SNB-78 | GI50 | 574.12 | nM | None |
| Homo sapiens | Sphingomyelin phosphodiesterase | Potency | 15848.9 | nM | None |
| Homo sapiens | SR | GI50 | 215.28 | nM | None |
| Homo sapiens | SW-620 | GI50 | 32.06 | nM | None |
| Homo sapiens | T47D | GI50 | 10.0 | nM | None |
| Homo sapiens | TK-10 | GI50 | 1629.3 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 130.0 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 163.6 | nM | None |
| Homo sapiens | Tyrosyl-DNA phosphodiesterase 1 | Potency | 39810.7 | nM | None |
| Homo sapiens | U-251 | GI50 | 10.76 | nM | None |
| Homo sapiens | UACC-257 | GI50 | 57.15 | nM | None |
| Homo sapiens | UACC-62 | GI50 | 10.21 | nM | None |
| Homo sapiens | Ubiquitin carboxyl-terminal hydrolase 1 | Potency | 35481.3 | nM | None |
| Homo sapiens | UO-31 | GI50 | 17.5 | nM | None |
| Homo sapiens | WiDr | ID50 | 3.2 | ng ml-1 | 10.1016/s0960-894x(02)00388-8 |
| Homo sapiens | XF498 | GI50 | 143.22 | nM | None |
| Klebsiella pneumoniae | Klebsiella pneumoniae | Inhibition | 8.25 | % | 10.6019/CHEMBL4296182 |
| Mus musculus | Heat shock factor protein 1 | AbsAC40_uM | 15.89 | uM | None |
| Mus musculus | Heat shock factor protein 1 | EC50 | 260000.0 | nM | None |
| Mus musculus | L1210 | Active dose range | 5.0 | mg kg-1 | 10.1021/jm00393a016 |
| Mus musculus | L1210 | IC50 | 12.0 | nM | 10.1021/jm00105a017 |
| Mus musculus | L1210 | IC50 | 12.7 | nM | 10.1016/0960-894X(96)00083-2 |
| Mus musculus | L1210 | IC50 | 12.7 | nM | 10.1016/S0960-894X(97)00105-4 |
| Mus musculus | L1210 | KE | 5.97 | None | 10.1021/jm00070a013 |
| Mus musculus | L1210 | Toxic dose | 10.0 | mg kg-1 | 10.1021/jm00393a016 |
| Mus musculus | Mus musculus | Cures | 3.0 | None | 10.1021/jm00070a013 |
| Mus musculus | Mus musculus | Highest active dose | 0.6 | mg kg-1 | 10.1021/jm00070a013 |
| Mus musculus | Mus musculus | ILS | 94.0 | % | 10.1021/jm00105a017 |
| Mus musculus | Mus musculus | MTD | 8.9 | uM kg-1 | 10.1021/jm00105a017 |
| Mus musculus | Mus musculus | No. of cures | 4.0 | None | 10.1021/jm00393a016 |
| Mus musculus | Mus musculus | T/C | 1.15 | None | 10.1021/jm00070a013 |
| Mus musculus | Mus musculus | T/C | 2.44 | None | 10.1021/jm00070a013 |
| Mus musculus | Mus musculus | T/C | 5.97 | % | 10.1021/jm00393a016 |
| Mus musculus | Mus musculus | T/C | 138.0 | % | 10.1016/0960-894X(96)00083-2 |
| Mus musculus | Mus musculus | T/C | 163.0 | % | 10.1016/0960-894X(96)00083-2 |
| Mus musculus | Mus musculus | T/C | 361.0 | % | 10.1021/jm00070a013 |
| Mus musculus | Mus musculus | T/C | 361.0 | % | 10.1021/jm00393a016 |
| Mus musculus | Mus musculus | Toxic dose | 10.0 | mg kg-1 | 10.1021/jm00070a013 |
| Mus musculus | Nuclear receptor ROR-gamma | Potency | 20.0 | nM | None |
| Mus musculus | Nuclear receptor ROR-gamma | Potency | 354.8 | nM | None |
| Mus musculus | P338 | Active dose range | 2.5 | mg kg-1 | 10.1021/jm00161a035 |
| Mus musculus | P338 | No. of cures | 4.0 | None | 10.1021/jm00161a035 |
| Mus musculus | P338 | T/C | 5.86 | % | 10.1021/jm00161a035 |
| Mus musculus | P338 | T/C | 348.0 | % | 10.1021/jm00161a035 |
| Mus musculus | P338 | Toxic dose | 10.0 | mg kg-1 | 10.1021/jm00161a035 |
| Mus musculus | P388 | GI50 | 11.91 | nM | None |
| Mus musculus | P388/ADR | GI50 | 17.38 | nM | None |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 1168.9 | nM | None |
| Plasmodium falciparum | Plasmodium falciparum | Potency | 1852.6 | nM | None |
| Pseudomonas aeruginosa | Pseudomonas aeruginosa | Inhibition | 22.5 | % | 10.6019/CHEMBL4296182 |
| Rattus norvegicus | INS1 | AC50 | 2132.0 | nM | None |
| Schistosoma mansoni | Thioredoxin glutathione reductase | Potency | 50118.7 | nM | None |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 1.64 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 7.6 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -0.03 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 0.01 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 80.32 | % | 10.21203/rs.3.rs-23951/v1 |
| Staphylococcus aureus | Staphylococcus aureus | Inhibition | 34.7 | % | 10.6019/CHEMBL4296182 |
| None | ADMET | CL | 6.5 | mL.min-1.kg-1 | 10.1124/dmd.108.020479 |
| None | ADMET | ED50 | 0.02 | ug ml-1 | 10.1021/jm00393a016 |
| None | ADMET | IC50 | 1.0 | nM | 10.1021/jm101354u |
| None | ADMET | IC50 | 90.0 | nM | 10.1021/jm101354u |
| None | ADMET | IC90 | 700.0 | nM | 10.1021/jm101354u |
| None | ADMET | MRT | 5.6 | hr | 10.1124/dmd.108.020479 |
| None | ADMET | Ratio | 75.0 | None | 10.1021/jm101354u |
| None | ADMET | Ratio | 88.0 | None | 10.1021/jm101354u |
| None | ADMET | T1/2 | 0.2983 | hr | 10.1021/jm00027a005 |
| None | ADMET | T1/2 | 0.39 | hr | 10.1021/jm00027a005 |
| None | ADMET | T1/2 | 7.0 | hr | 10.1124/dmd.108.020479 |
| None | ADMET | Vdss | 2.2 | L.kg-1 | 10.1124/dmd.108.020479 |
| None | NCI-H928 | IC50 | 7.9 | nM | 10.1021/jm990124q |
| None | NON-PROTEIN TARGET | AC50 | 2470.0 | nM | None |
| None | NON-PROTEIN TARGET | Fu | 0.003 | None | 10.1124/dmd.108.020479 |
| None | NON-PROTEIN TARGET | IC50 | 8.5 | nM | 10.1021/jm990124q |
| None | No relevant target | AC50 | 260.0 | nM | None |
| None | No relevant target | Solubility | 0.06 | mg kg-1 | 10.1021/jm990124q |
| None | No relevant target | Solubility | 6.0 | ug.mL-1 | 10.1021/jm990124q |
| None | Unchecked | AC50 | 260.0 | nM | None |
| None | Unchecked | AC50 | 348.0 | nM | None |
| None | Unchecked | AC50 | 463.0 | nM | None |
| None | Unchecked | Control | 73.0 | % | 10.1021/jm00070a013 |
| None | Unchecked | EC50 | 350000.0 | nM | None |
| None | Unchecked | IC50 | 160.0 | nM | None |
| None | Unchecked | IC50 | 620.0 | nM | None |
| None | Unchecked | IC50 | 6020.0 | nM | None |
| None | Unchecked | IC50 | 80000.0 | nM | None |
| None | Unchecked | Potency | 410.9 | nM | None |
| None | Unchecked | Potency | 920.0 | nM | None |
| None | Unchecked | Potency | 1000.0 | nM | None |
| None | Unchecked | Potency | 1258.9 | nM | None |
| None | Unchecked | Potency | 1299.5 | nM | None |
| None | Unchecked | Potency | 10000.0 | nM | None |
